Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

OVID holding history

Ovid Therapeutics Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OVID overviewAll 13F holders of OVIDFull Q2 2026 holdings

Shares (Q2 2026)
458,917
Value
$1.23M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of OVID by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026458,917$1.23M<0.1%+181,261+65.3%AddedHolders
Q1 2026277,656$616.4K<0.1%+84,671+43.9%AddedHolders
Q4 2025192,985$314.6K<0.1%−44,994−18.9%ReducedHolders
Q3 2025237,979$309.4K<0.1%+216,310+998.2%AddedHolders
Q2 202521,669$7.15K<0.1%−5,289−19.6%ReducedHolders
Q1 202526,958$8.41K<0.1%−33,809−55.6%ReducedHolders
Q4 202460,767$56.8K<0.1%+30,155+98.5%AddedHolders
Q3 202430,612$36.1K<0.1%+9,420+44.5%AddedHolders
Q2 202421,192$16.3K<0.1%−52,230−71.1%ReducedHolders
Q1 202473,422$223.9K<0.1%+1,489+2.1%AddedHolders
Q4 202371,933$231.6K<0.1%+23,826+49.5%AddedHolders
Q3 202348,107$184.7K<0.1%−1,519−3.1%ReducedHolders
Q2 202349,626$162.8K<0.1%+31,557+174.6%AddedHolders
Q1 202318,069$46.6K<0.1%+1,276+7.6%AddedHolders
Q4 202216,793$31.2K<0.1%−2,368−12.4%ReducedHolders
Q3 202219,161$36.0K<0.1%+3,216+20.2%AddedHolders
Q2 202215,945$34.0K<0.1%+945+6.3%AddedHolders
Q1 202215,000$47.0K<0.1%−4,277−22.2%ReducedHolders
Q4 202119,277$62.0K<0.1%+4,277+28.5%AddedHolders
Q3 202115,000$50.0K<0.1%00.0%UnchangedHolders
Q2 202115,000$59.0K<0.1%−5,037−25.1%ReducedHolders
Q1 202120,037$81.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.